Effect of modified alkaline supplementation on syngenic melanoma growth in CB57/BL mice

Tommaso Azzarito, Luana Lugini, Enrico Pierluigi Spugnini, Rossella Canese, Alessio Gugliotta, Stefano Fidanza, Stefano Fais

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Tumor extracellular acidity is a hallmark of malignant cancers. Thus, in this study we evaluated the effects of the oral administration of a commercially available water alkalizer (Basenpulver1) (BP) on tumor growth in a syngenic melanoma mouse model. The alkalizer was administered daily by oral gavage starting one week after tumor implantation in CB57/BL mice. Tumors were calipered and their acidity measured by in vivo MRI guided 31P MRS. Furthermore, urine pH was monitored for potential metabolic alkalosis. BP administration significantly reduced melanoma growth in mice; the optimal dose in terms of tolerability and efficacy was 8 g/l (p<0.05). The in vivo results were supported by in vitro experiments, wherein BP-treated human and murine melanoma cell cultures exhibited a dose-dependent inhibition of tumor cell growth. This investigation provides the first proof of concept that systemic buffering can improve tumor control by itself and that this approach may represent a new strategy in prevention and/or treatment of cancers.

Original languageEnglish
Article numbere0159763
JournalPLoS One
Volume11
Issue number7
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

melanoma
Tumors
Melanoma
neoplasms
mice
Growth
Neoplasms
Acidity
acidity
Cell growth
Cell culture
Alkalosis
Magnetic resonance imaging
dosage
oral administration
cell growth
mouth
cell culture
urine
Oral Administration

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Azzarito, T., Lugini, L., Spugnini, E. P., Canese, R., Gugliotta, A., Fidanza, S., & Fais, S. (2016). Effect of modified alkaline supplementation on syngenic melanoma growth in CB57/BL mice. PLoS One, 11(7), [e0159763]. https://doi.org/10.1371/journal.pone.0159763

Effect of modified alkaline supplementation on syngenic melanoma growth in CB57/BL mice. / Azzarito, Tommaso; Lugini, Luana; Spugnini, Enrico Pierluigi; Canese, Rossella; Gugliotta, Alessio; Fidanza, Stefano; Fais, Stefano.

In: PLoS One, Vol. 11, No. 7, e0159763, 01.07.2016.

Research output: Contribution to journalArticle

Azzarito, T, Lugini, L, Spugnini, EP, Canese, R, Gugliotta, A, Fidanza, S & Fais, S 2016, 'Effect of modified alkaline supplementation on syngenic melanoma growth in CB57/BL mice', PLoS One, vol. 11, no. 7, e0159763. https://doi.org/10.1371/journal.pone.0159763
Azzarito T, Lugini L, Spugnini EP, Canese R, Gugliotta A, Fidanza S et al. Effect of modified alkaline supplementation on syngenic melanoma growth in CB57/BL mice. PLoS One. 2016 Jul 1;11(7). e0159763. https://doi.org/10.1371/journal.pone.0159763
Azzarito, Tommaso ; Lugini, Luana ; Spugnini, Enrico Pierluigi ; Canese, Rossella ; Gugliotta, Alessio ; Fidanza, Stefano ; Fais, Stefano. / Effect of modified alkaline supplementation on syngenic melanoma growth in CB57/BL mice. In: PLoS One. 2016 ; Vol. 11, No. 7.
@article{e4d9019ae8984d108964fe9d367093a7,
title = "Effect of modified alkaline supplementation on syngenic melanoma growth in CB57/BL mice",
abstract = "Tumor extracellular acidity is a hallmark of malignant cancers. Thus, in this study we evaluated the effects of the oral administration of a commercially available water alkalizer (Basenpulver1) (BP) on tumor growth in a syngenic melanoma mouse model. The alkalizer was administered daily by oral gavage starting one week after tumor implantation in CB57/BL mice. Tumors were calipered and their acidity measured by in vivo MRI guided 31P MRS. Furthermore, urine pH was monitored for potential metabolic alkalosis. BP administration significantly reduced melanoma growth in mice; the optimal dose in terms of tolerability and efficacy was 8 g/l (p<0.05). The in vivo results were supported by in vitro experiments, wherein BP-treated human and murine melanoma cell cultures exhibited a dose-dependent inhibition of tumor cell growth. This investigation provides the first proof of concept that systemic buffering can improve tumor control by itself and that this approach may represent a new strategy in prevention and/or treatment of cancers.",
author = "Tommaso Azzarito and Luana Lugini and Spugnini, {Enrico Pierluigi} and Rossella Canese and Alessio Gugliotta and Stefano Fidanza and Stefano Fais",
year = "2016",
month = "7",
day = "1",
doi = "10.1371/journal.pone.0159763",
language = "English",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - Effect of modified alkaline supplementation on syngenic melanoma growth in CB57/BL mice

AU - Azzarito, Tommaso

AU - Lugini, Luana

AU - Spugnini, Enrico Pierluigi

AU - Canese, Rossella

AU - Gugliotta, Alessio

AU - Fidanza, Stefano

AU - Fais, Stefano

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Tumor extracellular acidity is a hallmark of malignant cancers. Thus, in this study we evaluated the effects of the oral administration of a commercially available water alkalizer (Basenpulver1) (BP) on tumor growth in a syngenic melanoma mouse model. The alkalizer was administered daily by oral gavage starting one week after tumor implantation in CB57/BL mice. Tumors were calipered and their acidity measured by in vivo MRI guided 31P MRS. Furthermore, urine pH was monitored for potential metabolic alkalosis. BP administration significantly reduced melanoma growth in mice; the optimal dose in terms of tolerability and efficacy was 8 g/l (p<0.05). The in vivo results were supported by in vitro experiments, wherein BP-treated human and murine melanoma cell cultures exhibited a dose-dependent inhibition of tumor cell growth. This investigation provides the first proof of concept that systemic buffering can improve tumor control by itself and that this approach may represent a new strategy in prevention and/or treatment of cancers.

AB - Tumor extracellular acidity is a hallmark of malignant cancers. Thus, in this study we evaluated the effects of the oral administration of a commercially available water alkalizer (Basenpulver1) (BP) on tumor growth in a syngenic melanoma mouse model. The alkalizer was administered daily by oral gavage starting one week after tumor implantation in CB57/BL mice. Tumors were calipered and their acidity measured by in vivo MRI guided 31P MRS. Furthermore, urine pH was monitored for potential metabolic alkalosis. BP administration significantly reduced melanoma growth in mice; the optimal dose in terms of tolerability and efficacy was 8 g/l (p<0.05). The in vivo results were supported by in vitro experiments, wherein BP-treated human and murine melanoma cell cultures exhibited a dose-dependent inhibition of tumor cell growth. This investigation provides the first proof of concept that systemic buffering can improve tumor control by itself and that this approach may represent a new strategy in prevention and/or treatment of cancers.

UR - http://www.scopus.com/inward/record.url?scp=84979716031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979716031&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0159763

DO - 10.1371/journal.pone.0159763

M3 - Article

AN - SCOPUS:84979716031

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e0159763

ER -